Xin Lang Cai Jing·2025-10-13 21:06Group 1 - Bristol Myers Squibb agrees to acquire Orbital Therapeutics for $1.5 billion in cash to enhance its cell therapy product portfolio, focusing on next-generation RNA drugs [1] - Fonda Holdings plans to acquire 100% of Shanghai Guanhua Medical Technology for RMB 270 million, which specializes in clinical trial technology services [2] - Shengxing Holdings announces the acquisition of machinery from A and B sellers for a total of HKD 6.45 million and HKD 6.2 million, respectively, along with a financing lease agreement [3] Group 2 - Jiufu Lai completes the acquisition of 100% equity in Henan Lixuan Network Technology, with all conditions met for the transaction [4] - Zijin Mining completes the acquisition of 100% equity in the Raygorodok gold mine project in Kazakhstan, which has rich resources [5] - Luxshare Precision announces progress in acquiring equity and assets from subsidiaries of Wentech Technology [6] Group 3 - Tianjin Jieqiang Power Equipment completes the acquisition of 51% equity in Shandong Carbon Seeking New Materials as part of its strategic development plan [7] - Global Infrastructure Partners (GIP) is in advanced negotiations to acquire Aligned Data Centers from Macquarie Group, with a potential transaction value of up to $40 billion [8]